ETS1 and central nervous system cancer: By analyzing the expression differences of these 4 transcription factors from GSE50161 chip in normal samples and glioma tumor samples, it was noted that ETS1 was remarkably upregulated in tumor samples (Figure 4(b)) with the most prominent difference when compared with the normal samples (∣logFC | = 2.558219) (Table S4).